Science Translational Medicine publishes original, peer-reviewed, science-based research articles that report successful advances toward the goal of improving patients' lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts hold Science Translational Medicine articles to the same high-quality standard that is the hallmark of the journal Science.
Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
Examples of content in Science Translational Medicine:
Investigative studies of human biology with an emphasis on disease, including small clinical trials
Research on models of human disease with significant implications for disease treatment
Focus, Perspectives and Reviews that discuss medically related research from a basic science and a clinical point of view
Commentary on policy, funding, education and regulatory issues in translational medicine
Survey of recent noteworthy findings from other publications (Editor's Choice)
Special issues that feature comprehensive reviews and analyses of current topics in translational medicine
Audience: Researchers and management in academia, government, and the biotechnology and pharmaceutical industries; physician scientists; regulators; policy makers; investors; business developers; and funding agencies.
http://stm.sciencemag.org/site/misc/about.xhtml